Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07658508
PHASE2/PHASE3

Topical Calcipotriol Versus Photodynamic Therapy in the Treatment of Oral Leukoplakia

Sponsor: Alexandria University

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to learn if calcipotriol and photodynamic therapy are equally effective in treatment of leukoplakia or not. The main questions it aims to answer are: do lesions decrease or disappear when treated by calcipotriol or PDT? does the drug affect the salivary biomarkers Participants will: Take calcipotriol daily for 4 weeks or perform 4 PDT sessions over 4 weeks measure changes in salivary biomarkers be followed up for 3 months

Official title: Topical Calcipotriol Gel Versus Photodynamic Therapy in the Treatment of Oral Leukoplakia: Randomized Clinical Trial

Key Details

Gender

All

Age Range

25 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2025-07-16

Completion Date

2026-09-10

Last Updated

2026-06-22

Healthy Volunteers

No

Interventions

DRUG

Calcipotriol 0.005% gel

using prepared calcipotriol in orabase twice daily for 4 weeks

DEVICE

ALA mediated PDT

applying photodynamic therapy using laser device on photosensitizer

Locations (1)

Faculty of Dentistry, Alexandria University

Alexandria, Egypt